GLAXOSMITHKLINE PLC

GSK

Delayed - 04/15 11:35:28 am
1348.4GBX	+4.56%

04/28/21 \| 07:00am	Q1 2021 Earnings Release
04/28/21 \| 09:00am	Q1 2021 Earnings Call
05/05/21 \| 09:30am	Annual General Meeting
06/23/21 \| 09:00am	Investor Meeting - Day - 1

03/17/21 \| 06:55am	Bioprocessing Europe Conference
02/18/21	Ex-dividend day for final dividend
02/03/21 \| 09:00am	FY 2020 Earnings Call
02/03/21 \| 07:00am	FY 2020 Earnings Release

04/15/21 \| 02:30am	BETTA PHARMACEUTICALS CO., LTD. : Annual General Meeting
04/15/21	GAN & LEE PHARMACEUTICALS CO., LTD. : FY 2020 Earnings Release
04/15/21	TWIST BIOSCIENCE CORPORATION : Korean Society of Biotechnology and Bioengineering Spring Meeting and International Symposium
04/15/21 \| 08:00am	RICHTER GEDEON VEGYéSZETI GYáR NYILVáNOSAN MUKöDO RT. : Annual General Meeting

04/14/21 \| 11:00am	TWIST BIOSCIENCE CORPORATION : Decoding transcriptional regulation using massively parallel reporter assays and Twist Oligo Pools W
04/14/21	VIFOR PHARMA AG : Roadshow
04/14/21	VIFOR PHARMA AG : Roadshow
04/14/21	MERCK KGAA : Critical Materials Conference

Previous year

Next Year

Annual results		2016	2017	2018	2019	2020	2021 (e)
Sales M GBP	Released Forecast Spread	27 889 27 682 0,75%	30 186 30 092 0,31%	30 821 30 564 0,84%	33 754 33 382 1,1%	34 099 34 076 0,07%	33 614
Operating income (EBITDA) M GBP	Released Forecast Spread	9 632 9 332 3,2%	10 270 10 224 0,45%	10 508 10 277 2,2%	11 968 11 155 7,3%	9 530 10 575 -9,9%	9 641
Operating profit (EBIT) M GBP	Released Forecast Spread	7 771 7 633 1,8%	8 568 8 576 -0,10%	8 745 8 605 1,6%	8 972 9 182 -2,3%	8 906 8 955 -0,55%	8 171
Pre-Tax Profit (EBT) M GBP	Released Forecast Spread	1 939 2 433 -20%	3 525 4 806 -27%	4 800 5 259 -8,7%	6 221 5 891 5,6%	6 968 6 738 3,4%	5 865
Net income M GBP	Released Forecast Spread	912 1 817 -50%	1 532 3 279 -53%	3 623 3 540 2,4%	4 645 4 026 15%	5 749 4 894 17%	3 797
EPS GBP	Released Forecast Spread	0,19 0,39 -52%	0,31 0,68 -55%	0,74 0,72 2,8%	0,93 0,84 9,7%	1,14 0,97 18%	0,77
Announcement Date		02/08/2017	02/07/2018	02/06/2019	02/05/2020	02/03/2021

Previous period

Next period

Quarterly results		2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1 (e)	2021 Q2 (e)	2021 Q3 (e)	2021 Q4 (e)	2022 Q1 (e)
Sales M GBP	Released Forecast Spread	8 092 7 945 1,8%	8 197 8 046 1,9%	7 661 7 522 1,8%	7 809 7 580 3,0%	9 385 8 982 4,5%	8 899 8 920 -0,23%	9 090 8 621 5,4%	7 624 7 734 -1,4%	8 646 8 697 -0,59%	8 739 8 715 0,28%	8 068	7 705	8 787	8 876	9 138
Operating income (EBITDA) M GBP	Released Forecast Spread	3 020 2 901 4,1%	2 790 2 498 12%	3 346 2 417 38%	2 947 2 397 23%	3 299 3 029 8,9%	2 376 2 578 -7,8%	2 869 2 898 -0,99%	2 526 2 339 8,0%	2 024 2 919 -31%	2 111 2 478 -15%
Operating profit (EBIT) M GBP	Released Forecast Spread	2 524 2 387 5,8%	2 196 2 096 4,8%	2 163 1 962 10%	2 171 1 972 10%	2 786 2 561 8,8%	1 852 2 132 -13%	2 675 2 424 10%	1 749 1 759 -0,59%	2 665 2 343 14%	1 817 1 920 -5,3%	1 843	1 844	2 518	1 958
Pre-Tax Profit (EBT) M GBP	Released Forecast Spread		1 374 1 018 35%	1 295 1 116 16%	1 264 1 140 11%	1 951 1 785 9,3%	1 711 658 160%	1 835 1 282 43%	2 641 4 477 -41%	1 671 1 676 -0,27%	821 869 -5,5%	882	1 303	1 950	1 271
Net income M GBP	Released Forecast Spread	1 418 1 399 1,4%	1 215 992 22%	830 930 -11%	964 906 6,4%	1 552 1 317 18%	1 299 671 94%	1 565 855 83%	2 263 1 718 32%	1 244 878 42%	677 162 317%	497	850	1 374	785
EPS GBP	Released Forecast Spread	0,29 0,28 1,1%	0,25 0,21 15%	0,17 0,19 -11%	0,19 0,17 11%	0,31 0,27 15%	0,26 0,13 94%	0,31 0,21 49%	0,46 0,34 33%	0,25 0,17 44%	0,13 0,01 2 424%	0,10	0,17	0,27	0,16
Announcement Date		10/31/2018	02/06/2019	05/01/2019	07/24/2019	10/30/2019	02/05/2020	04/29/2020	07/29/2020	10/28/2020	02/03/2021